Cathie Wood’s Q3 13F: ARK Buys Nvidia and SpaceX, Dumps Half Its AMD
Cathie Wood's ARK Invest grew its portfolio to $17.4B in Q3 2026, loading up on Nvidia and SpaceX while slashing AMD and paring back genomic diagnostics.
Cathie Wood’s ARK Investment Management expanded its US equity portfolio to $17.4 billion across 182 holdings in the third quarter of 2026, up from $15.4 billion in the prior quarter, according to regulatory disclosures filed on Friday, November 13. The filing reveals an aggressive reallocation toward high-conviction mega-trends, marked by massive additions to Nvidia, SpaceX, and Meta alongside steep cuts to semiconductor peer AMD and genomic diagnostics.
Form 13F filings reflect US long equity positions as of September 30, 2026, and are released under a standard 45-day reporting lag, excluding non-US listings, short positions, and cash equivalents.
What happened
ARK initiated nine new positions during the third quarter while concentrating capital into existing high-conviction positions and clearing out fringe holdings. The firm completely liquidated 18 stakes, including Strata Critical Medical, Honeywell International, Teva Pharmaceutical Industries, Kamada, Enlivex, and Nano-X Imaging, simplifying the tail of its portfolio.
The most dramatic trading activity took place across AI hardware, commercial space infrastructure, and digital assets. ARK boosted its share count in Nvidia by 85%, lifting the chipmaker to 3.37% of the portfolio. Simultaneously, Wood slashed her position in Advanced Micro Devices by 52%, dropping AMD's portfolio weight to 2.38%. This stark divergence signals an active rotation back into Nvidia during third-quarter sector consolidation, well before the heightened volatility and leadership transitions that unfolded in November.
ARK also increased its holding in SpaceX (SPCX) by 51%, solidifying the aerospace firm as ARK’s second-largest asset at 5.86% of the portfolio. Flagship holding Tesla remained the top position at 6.89% after a 22% share increase, reinforcing Wood's long-standing focus on autonomous transport.
Further down the roster, ARK expanded its stake in Meta Platforms by 105% to reach a 2.04% weight, while lifting AI cloud provider CoreWeave by 58% to 2.11%. In digital finance, Wood added 50% more shares of stablecoin issuer Circle Internet Group, lifting it to a 3.24% allocation, and raised Coinbase Global by 17% to 3.14%. To fund these purchases, ARK trimmed diagnostics pioneers, cutting 10X Genomics by 37% and Twist Bioscience by 25%, while peeling back retail brokerage Robinhood Markets by 12%.
Why it matters
The third-quarter portfolio reshuffle underscores a deliberate thematic recalibration by Cathie Wood. Rather than spreading dry powder across speculative venture bets, ARK consolidated around dominant infrastructure gatekeepers.
The sharp pivot between Nvidia and AMD highlights Wood's willingness to exploit short-term valuation dislocations. After AMD shares surged past $600 during the third quarter on AI chip market-share optimism, ARK locked in substantial gains. Wood redeployed that capital into Nvidia ahead of recent fourth-quarter volatility, betting that enterprise demand for GPU compute remains intact regardless of headline friction.
At the same time, ARK's combined allocation to Elon Musk’s enterprises—Tesla and SpaceX—now represents 12.75% of the fund’s total US equity assets. This concentration demonstrates heightened conviction in physical AI, robotics, and commercial orbital infrastructure, eclipsing Wood's earlier emphasis on early-stage life sciences. The substantial trim in genomic tools like Twist Bioscience and 10X Genomics indicates that capital-intensive biotechnology continues to take a back seat to cash-generating software platforms and AI infrastructure plays.
Circle’s elevation into the top ten, now representing 3.24% of the fund, mirrors ARK's institutional thesis on regulated stablecoin rails. With Circle reporting $865 million in quarterly revenue on expanding cross-border network volume, ARK appears to favor infrastructure operators that profit from blockchain settlement activity over speculative retail trading venues.
What to watch next
- Nvidia Q3 earnings: How data center revenue and Blackwell delivery schedules hold up following leadership restructuring, with the stock trading around $161 as of mid-November 2026.
- SpaceX orbital cadence: Commercial deployment progress and launch milestones following the successful Starship upper-stage recovery tower catch.
- CoreWeave balance-sheet health: Progress on refinancing debt and lowering interest expenses from 23% of revenue through asset-backed facilities and GPU collateral.
- Genomic rebalancing trends: Whether ARK stabilizes its life sciences allocations or continues paring tools providers to finance hyperscale compute.
Stocks in this analysis
AI stock analysis- P/E
- 417.3
- Fwd P/E
- 175.9
- Analyst target (avg)
- $412.48 (+9%)
- P/E
- 19.7
- Fwd P/E
- 9.8
- Analyst target (avg)
- $268.76 (+72%)
- P/E
- 107.3
- Fwd P/E
- 28.5
- Analyst target (avg)
- $657.74 (+31%)
Free on aktienanalyse.ai: score profile, ratios versus the industry and business model. Plus, if you want it, the full analysis with fair value and bull, base and bear case. Prices and ratios as of Nov 16, 2026.
Sources (2)
This analysis is for information only and is not investment advice. Prices and figures as of publication.